Measles is a highly infectious, acute viral disease that causes a characteristic maculopapular rash, respiratory symptoms, and fever. Measles-related complications include diarrhea (affecting 8% of case-patients), otitis media (7%-9%), pneumonia (1%-6%), and encephalitis (1-2 per 1000 case-patients) [1] . Death occurs in 1-3 per 1000 cases [1] . In the prevaccine era, an estimated 3-4 million people in the United States became infected with measles annually, of whom 500 000 were reported. Of the reported cases, 500 persons died, 48 000 were hospitalized, and 4000 reported measles encephalitis annually [1] .
High population immunity is the most effective way to prevent measles. The national measles vaccine program launched in 1963. Today, the United States recommends 2 doses of measles-mumps-rubella (MMR) vaccine for all school-aged children and high-risk adults born during or after 1957 (ie, healthcare personnel, international travelers, and students at post-high school educational institutions) [2] . State laws require age-appropriate vaccination of children enrolled in childcare facilities and documentation of evidence of measles immunity upon entry into kindergarten or first grade [3] . For non-high-risk adults born during or after 1957 and preschool-aged children who lack evidence of measles immunity, 1 dose of MMR vaccine is recommended [2] .
The national measles vaccination program has achieved and maintained high 1-and 2-dose MMR vaccine coverage in preschool-and school-aged children. That success, coupled with improved control of measles throughout the Americas, resulted in the declaration of measles elimination in the United States in 2000 [4] . Elimination is the absence of endemic disease transmission (ie, no epidemiological or virological evidence that measles virus transmission is continuously occurring for ≥12 months in a defined geographical area that has adequate surveillance) [4] . In December 2011, an external expert panel verified that the United States sustained elimination of measles from 2001 to 2011 [5] .
However, as of 2012, there were still an estimated 20 million cases of measles globally [6] and 145 700 measles-related deaths annually [7] , with extensive outbreaks in 2013 and 2014 occurring in the World Health Organization (WHO)'s European and Western Pacific Regions [8, 9] . As a result of importations of measles virus from abroad and subsequent spread into large unvaccinated communities, in 2014, the United States experienced the most measles cases and the largest measles outbreak in 20 years.
We previously reported on measles epidemiology in the United States from 2001 to 2008 [10] . In this report, we summarize measles epidemiology in the United States during the postelimination years 2009-2014 and compared the findings with earlier postelimination years.
METHODS
All states legally mandate that healthcare personnel and clinical laboratories report measles cases to their respective local health departments. Measles surveillance is a passive reporting system that is activated when a suspected measles case is reported. This triggers a search for additional case-patients that might have had contact with the suspect case-patient. The sensitivity of the system is increased through reporting and a thorough investigation of all suspected case-patients.
Measles cases were identified and classified using standard case definitions and case classification [11] . A confirmed case of measles was either laboratory-confirmed or had a direct epidemiological linkage to a patient with laboratory-confirmed measles infection [11] . State health departments reported confirmed cases of measles to the National Center for Immunization and Respiratory Diseases at the Centers for Disease Control and Prevention (CDC) via telephone or e-mail [12] and electronically to the National Notifiable Diseases Surveillance System [13] .
An outbreak of measles in the United States was defined as a chain of transmission with ≥3 confirmed cases. We analyzed all cases and outbreaks of measles reported in the United States during 2009-2014. Comparisons were made with epidemiological data from 2001 to 2008. Differences in medians were calculated by Wilcoxon rank sums, and differences in proportions were calculated by Mantel-Haenszel χ 2 in SAS 9.3 (Cary, North Carolina).
Cases were classified either as internationally imported (ie, exposure to measles virus occurred outside the United States 7-21 days before rash onset and rash developed within 21 days of entrance into the United States, with no known exposure to measles occurring in the United States during that time) or US-acquired (ie, case-patients either had not been outside the United States during the 21 days before rash onset or were known to have been exposed to measles within the United States). United States-acquired cases were subclassified into 4 mutually exclusive groups: (1) import-linked (ie, any case in a chain of transmission that was epidemiologically linked to an internationally imported case), (2) imported-virus (ie, cases in which an epidemiologic link to an internationally imported case was not identified but viral genetic evidence indicated an imported measles genotype within the chain of transmission), (3) endemic (ie, cases in which transmission of measles virus was continuous for ≥12 months within the United States), and (4) unknown source (ie, cases in which an epidemiological or virological link to importation or to endemic transmission within the United States could not be established after a thorough investigation) [13, 14] .
Measles genotyping was performed at the CDC by the Vaccine Preventable Disease Reference Laboratories [15] using standard methods [16] . Sequence data were submitted to the WHO Global Measles Sequence Database (MeaNS) [17, 18] . Genotyped viral isolates were categorized by the WHO region (ie, African Region, Region of the Americas, South-East Asia Region, European Region, Eastern Mediterranean Region, or Western Pacific Region) from which the virus was imported, if known.
Index case-patients were defined as having the first rash onset in the 2-case chain or outbreak; co-index case-patients were defined as patients who had rash onset within 6 days of the index case-patient. We differentiated between US-resident and foreign-visitor case-patients (ie, foreign tourists, international students, new international adoptees, recent immigrants, refugees, and cruise ship employees) when we calculated incidence so that we could use US Census data as the denominator [19] , as well as when we reported vaccination status, because US vaccination recommendations apply only to US residents. This categorization allowed the differentiation of cases that would have been preventable had the recommended vaccination policy been implemented. Nonpreventable cases were defined as measles cases that occurred among US residents who either (1) had received ≥1 dose of measles-containing vaccine, (2) were vaccinated as recommended if traveling internationally, (3) were not vaccinated but had other evidence of immunity (ie, were born before 1957 and, therefore, were presumed to be immune from natural disease in childhood, had laboratory evidence of immunity), or (4) belonged to a category (such as infants <1 year of age) for whom MMR vaccination is not recommended on a routine basis. "Philosophical or religious objectors" were defined as persons who were vaccine eligible, according to recommendations of the Advisory Committee on Immunization Practices [2] or the WHO [7] , but remained unvaccinated because of personal or parental philosophical or religious beliefs.
We examined the rates of national 1-dose measles vaccination coverage among children 19-35 months of age and 2-dose measles vaccination coverage among adolescents from 2009 through 2014 using data from the National Immunization Survey, which supplies provider-verified, population-based rates of immunization with 95% confidence intervals. Compared to earlier postelimination years between 2001 and 2008, when the annual median number of cases reported was 56 cases/year (range, 37-140), the annual median number of cases during 2009-2014 was more than double [10] , but the difference was not statistically significant (Table 1) .
Of 1264 reported case-patients during 2009-2014, 682 (54%) were male. The median age of case-patients was 14 years (range, 1 day to 84 years). There were 115 (9%) case-patients <1 year, 254 (20%) 1-4 years, 136 (11%) 5-9 years, 255 (20%) 10-19 years, 222 (18%) 20-29 years, 135 (11%) 30-39 years, 91 (7%) 40-49 years, 54 (4%) were ≥50 years, and 2 (0.2%) were missing age information (Figure 2 ). Of those aged 1-4 years, 72 (28%) were aged 12-15 months. Among US resident case-patients from 2009 to 2014, children aged 12-15 months had the highest incidence of measles of any age group (65 cases, or 8.3 cases/million person-years), and infants aged 6-11 months had the second highest incidence (86 cases, or 7.3 cases/million person-years). The incidence rate for children aged 12-15 months more than tripled compared with 2001-2008 when incidence rates were 2.6 cases/million person years, and for infants aged 6-11 months, incidence rates doubled compared with 2001-2008 when rates were 3.5 cases/million person-years.
Complications were reported for 109 (9%) case-patients, including (in nonmutually exclusive categories) the following: 41 (38%) with diarrhea, 36 (33%) with pneumonia, 27 (25%) with dehydration, 17 (16%) with otitis media, 11 (10%) with thrombocytopenia, 3 (3%) with encephalitis, 1 In the previously published summary of measles epidemiological data from 2001 to 2008 [10] , the annual median number of outbreak-related case-patients was 5. In that article, there were 3 smaller outbreaks that were recategorized as 1 larger outbreak by the health department after the article was published. This resulted in a slight shift in the median number of outbreak-related case-patients.
(1%) with pancytopenia, and 1 (1%) with hepatitis. [10] .
Among the 392 index and co-index case-patients during 2009-2014, 225 (57%) were unvaccinated, 61 (16%) were vaccinated, and 106 (27%) had an unknown vaccination status. Among the 872 non-index and non-co-index (ie, spread) case-patients, 697 (80%) were unvaccinated, 65 (8%) were vaccinated, and 110 (13%) had an unknown vaccination status. The median age of the index and co-index case-patients was 20 years compared with 13 years among the spread case-patients.
Of 931 case-patients associated with measles outbreaks during 2009-2014, 744 (81%) were unvaccinated, 66 (7%) were vaccinated, and 121 (13%) had an unknown vaccination status, whereas of the 333 case-patients not associated with measles outbreaks, 178 (54%) were unvaccinated, 60 (18%) were vaccinated, and 95 (29%) had an unknown vaccination status. The proportion of case-patients associated with measles outbreaks who were unvaccinated or had unknown vaccination status (93%) was higher than the proportion unvaccinated or who had unknown vaccination status who were not associated with outbreaks (82%) (P < .0001). On an annual basis, the proportion of case-patients who were unvaccinated or who had an unknown vaccination status ranged from 78% in 2012 to 92% in 2013.
National rates of 1-dose vaccination coverage among children 19-35 months of age ranged from 90% to 92% from 2009 Three subjects were excluded because they were missing data on age or residency.
to 2013, compared with rates of 91% to 93% for 2001-2008 [20] . Rates of 2-dose coverage among adolescents ranged from 89% to 92% from 2009 to 2014, compared with rates of 87% to 89% for 2006-2008, which are the only years for which 2-dose coverage data were available [21] . Of the 1171 measles cases that occurred among US residents for whom we had data on age, 917 (78%) were considered preventable (Table 3) , compared with 65% of US-resident case-patients from 2001 to 2008 (P < .01) [10] . Of the preventable cases during 2009-2014, 758 (83%) were acquired in the United States. Of the 194 US-resident case-patients who traveled internationally, 170 (88%) were unvaccinated or had an unknown vaccination status; of whom 159 (94%) were considered to have preventable measles, including 28 (18%) who were aged 6-11 months. Six hundred (65%) of 917 vaccine-eligible US-resident case-patients were reported as having a philosophical or religious objection to vaccination during 2009-2014, similar to 68% from 2004 to 2008, the only years data were available (P = .54). (68%) were import-linked cases, 256 (26%) were imported-virus or epidemiologically linked to imported-virus cases, 0 were endemic cases, and 60 (6%) cases were of an unknown source. The transmission setting was known for 709 (72%) of the 989 US-acquired cases. In nonmutually exclusive categories, transmission occurred in the home for 504 cases (71%), in the community for 295 (42%), in a healthcare facility for 55 (8%), at church for 49 (7%), at nonhealthcare occupational settings for 19 (3%), at a childcare center for 14 (2%), at school for 6 (1%), and at other locations for 22 case-patients (3%).
During 2009-2014, a measles genotype was obtained from 143 (52%) of 275 imported cases and 61 (92%) of 66 outbreaks. Among genotypes obtained from imported and US-acquired case-patients, B3 was the predominant measles genotype identified during 2009-2014, comprising 152 (35%) of the 434 genotypes reported. The other genotypes identified were D8 (101, 23%), D4 (89, 21%), D9 (64, 15%), H1 (18, 4%) , and G3 (6, 1%). Final genotype results were missing on 4 (1%) specimens that were tested. These genotypes are associated with endemic transmission in many countries in Asia, Africa, and Europe. Cases were defined as nonpreventable if they occurred among US-resident case-patients who had received ≥1 dose of measles containing vaccine, were vaccinated as recommended if traveling internationally, or were not vaccinated but had other evidence of measles immunity (ie, were born before 1957 and therefore were presumed to be immune from natural disease in childhood, had laboratory evidence of immunity, or laboratory confirmation of disease) or for whom vaccination is not recommended.
c Of the 87 case-patients aged 30-39 years who were unvaccinated or had unknown vaccination status who did not travel internationally, 86 were preventable. The nonpreventable case-patient had a documented positive measles titer.
d
Of the 32 case-patients ≥40 years who were unvaccinated or had unknown vaccination status who traveled internationally, 22 were preventable. All 10 nonpreventable case-patients were persons born before 1957 (measles-containing vaccine is not recommended for people in this age group, because they are presumed to be immune from natural disease in childhood).
e Of the 87 case-patients aged ≥40 years who were unvaccinated or had unknown vaccination status who did not travel internationally, 77 were preventable. Of the 10 nonpreventable case-patients, 8 occurred in persons born before 1957 (measles-containing vaccine is not recommended for people in this age group, because they are presumed to be immune from natural disease in childhood) and 2 case-patients had documented positive measles titers. Table 4 , with 4 (50%) of the outbreaks with ≥20 case-patients occurring primarily among philosophical or religious objectors. [22] [23] [24] [25] [26] .
Globally, 20 million cases of measles occur annually [27] . In recent years, there have been numerous outbreaks with tens of thousands of cases reported on multiple continents, including countries that are traveled to frequently by US residents [27] . From 2009 to 2014, the highest number of imported cases into the United States were from the WHO European Region, but all regions outside of the Americas are a continued source of importations. Measles importations reflected both the incidence of measles in countries around the world and travel patterns. Unvaccinated US residents returning from trips abroad comprised the majority of imported measles cases in the United States, as opposed to foreign visitors. Between 2012 and 2014, the United States experienced the arrival of an average of 12.2 million nonresidents from Western Europe annually [28] [29] [30] , and 11.5 million US citizens traveled to European countries annually [31, 32] ; however, it experienced a much smaller number of travelers to and from Africa and Asia [28] [29] [30] [31] [32] , where the incidence of measles is higher [27] .
MMR vaccination coverage in the United States has remained stable with 90%-92% 1-dose coverage among children aged [20] and 89%-92% 2-dose coverage for adolescents during 2009-2014 [21] . Elimination was achieved with the current vaccination coverage levels and has not decreased on a national level since elimination was declared [4, 20] . Although 10% of case-patients during 2009-2014 were among vaccinated US residents, this has not changed since elimination because of the effectiveness of the measles component of the MMR vaccine and the high MMR vaccination coverage of the population. It is also reassuring that although tens of thousands of people were likely exposed from the 1264 case-patients, relatively few exposed vaccinated individuals actually became infected due to high population immunity.
19-35 months from 2009 to 2013
Measles outbreaks often began among unvaccinated individuals returning to the United States after being infected abroad and were subsequently sustained in pockets where unvaccinated people resided. Clustering among unvaccinated people is a common phenomenon and facilitates the spread of the virus [33] . Unvaccinated persons comprised the overwhelming majority of cases and outbreaks during 2009-2014, and over two thirds of US-resident case-patients were reported as having a philosophical or religious objection. Case-patients who were reported as having personal or philosophical objections belonged to diverse subpopulations that spanned the spectrum on socioeconomic status as well as political and religious ideologies [34] [35] [36] [37] [38] .
The highest incidence of measles during 2009-2014 occurred among children aged 12-15 months, illustrating a risk for measles in young children around the recommended age for the first MMR dose. Recent data from 11 206 parents of children aged 24-35 months at the time of the 2009 National Immunization Survey has shown that 26% delayed, 8% refused, and 6% both delayed and refused vaccines [39] . Thus, it is important for healthcare personnel to follow measles vaccine policy recommendations for age-appropriate and timely vaccination and to engage parents who have concerns about vaccinating their children.
Healthcare personnel also have a role in rapidly identifying individuals who might be suspect measles cases. In recent measles outbreaks, measles was not considered in the differential diagnosis during the patient's arrival at the healthcare facility [40, 41] . Thus, the implementation of airborne precautions was often either delayed or not done at all [42] . In addition, late recognition of measles delays contact tracing and the implementation of appropriate quarantine measures, resulting in more exposures.
Although the overall percentage of hospitalizations was lower during 2009-2014 (17%) compared with 2001-2008 (23%), the annual median number of hospitalized case-patients was higher during 2009-2014 compared with the earlier postelimination years (23 vs 16 case-patients annually, respectively). This is despite the fact that specific groups who were affected by measles during 2009-2014 were less likely to seek medical care (eg, Amish), even when they reported complications. Nonetheless, measles patients are often sick enough that at least half seek medical evaluation [42] .
Two of the larger outbreaks during 2009-2014 had unknown source cases, but the genotype of the imported virus was identified. Molecular epidemiology has been particularly useful when there are unknown source cases by identifying genotypes that are circulating in countries that have not yet eliminated measles. This has provided further assurance that these unknown source cases are the result of imported virus rather than by circulation of an endemic genotype in the United States. The The 2014 California outbreak continued into 2015 (and was much larger and affected additional states than the total reported here). However, this report only included data through week 52 in 2014.
An additional case-patient with unknown vaccination status was reported as having a philosophical or religious objection but was not included in this cell because the denominator only included unvaccinated case-patients (not those with unknown vaccination status).
molecular epidemiology analyses are facilitated by the global measles sequence database, MeaNS, which now contains sequences from over 22 000 cases. This allows for timely tracking of transmission chains on a global scale [18] .
CONCLUSIONS
Although the United States has maintained measles elimination since 2000, measles outbreaks continue to occur globally, and, therefore, the United States remains at risk of imported measles and potential spread. Measles is highly contagious, and when the virus lands in communities with pockets of unvaccinated individuals, it can lead to outbreaks. Although these outbreaks have been controlled and the overall population susceptibility to measles remains low in the United States, they require resource-intensive public health responses to contain them, and they divert resources from other public health activities. Early recognition of cases is challenging given the overall low number of cases in the United States, but it is critical to limiting transmission. In the current environment where measles is ubiquitous outside the Western Hemisphere, it will be necessary to have a committed global response to eradicate measles, as well as ensure that the United States maintains high 2-dose vaccination coverage, continues case-based surveillance, and monitors the patterns and rates of vaccine exemption to maintain measles elimination.
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